Showing 1 - 18 results of 18 for search 'Heiko Schoder', query time: 0.06s
Refine Results
-
1
-
2
TriDFusion (3DF) image viewer by Daniel Lafontaine, C. Ross Schmidtlein, Assen Kirov, Ryan P. Reddy, Simone Krebs, Heiko Schöder, John L. Humm
Published 2022-10-01
Article -
3
-
4
Concordance between Response Assessment Using Prostate-Specific Membrane Antigen PET and Serum Prostate-Specific Antigen Levels after Systemic Treatment in Patients with Metastatic... by Sangwon Han, Sungmin Woo, Yong-il Kim, Jae-Lyun Lee, Andreas G. Wibmer, Heiko Schoder, Jin-Sook Ryu, Hebert Alberto Vargas
Published 2021-04-01
Article -
5
Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy by Aurélien Marabelle, Samy Ammari, Eric Deutsch, Michael Farwell, Heiko Schöder, Lawrence H Schwartz, Binsheng Zhao, Laurent Dercle, Jeremy McGale, Shawn Sun, Randy Yeh, Fatima-Zohra Mokrane
Published 2022-09-01
Article -
6
Online searches for hepatocellular carcinoma drugs mirror prescription trends across specialties and changes in guideline recommendations by Philipp Berning, Adrian E. Schroer, Rishav Adhikari, Alexander C. Razavi, Francois H. Cornelis, Joseph P. Erinjeri, Stephen B. Solomon, Debkumar Sarkar, Hebert Alberto Vargas, Heiko Schöder, Josef J. Fox, Omar Dzaye, Omar Dzaye
Published 2024-02-01
Article -
7
Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis by Pallawi Torka, Levi D. Pederson, Michael V. Knopp, David Poon, Jun Zhang, Brad S. Kahl, Howard R. Higley, Gary Kelloff, Jonathan W. Friedberg, Lawrence H. Schwartz, Wyndham H. Wilson, John P. Leonard, Nancy L. Bartlett, Heiko Schöder, Amy S. Ruppert
Published 2023-04-01
Article -
8
P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patie... by Simonetta Viviani, Chiara Pavoni, Sally F. Barrington, Luca Guerra, Heiko Schöder, Peter Johnson, Amy A. Kirkwood, Deborah M. Stephens, Jonathan W. Friedberg, Stephane Chauvie, Michael V. Knopp, Massimo Federico, Gunilla Enblad, Paolo Corradini, Andrea Gallamini, Alessandro Rambaldi, Corrado Tarella
Published 2022-10-01
Article -
9
[18F]TFB PET/CT misses intense [124I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer by Philipp Backhaus, Keith S. Pentlow, Alan L Ho, Audrey Mauguen, James A Fagin, Naga Vara Kishore Pillarsetty, Serge K. Lyashchenko, Eva Burnazi, Ronald A. Ghossein, Shalini Chhabra, Murad Abusamra, Steven M. Larson, Heiko Schöder, Joseph O’Donoghue, Wolfgang Weber, Ravinder K. Grewal
Published 2024-10-01
Article -
10
P107: Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: a Large Multi-Trial Analysis Based on Ind... by Julia Driessen, Fer De Wit, Alex F. Herrera, Pier Luigi Zinzani, Ann S. Lacasce, Peter D. Cole, Craig H. Moskowitz, Ramón. García Sanz, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée. M. Zijlstra, Barbara A. Hutten, Alison J. Moskowitz, Marie José Kersten
Published 2022-10-01
Article -
11
Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good longterm outcomes by Paola Ghione, Salma Ahsanuddin, Efrat Luttwak, Sabela Bobillo Varela, Reiko Nakajima, Laure Michaud, Kanika Gupta, Anastasia Navitski, David Straus, M. Lia Palomba, Alison Moskowitz, Ariela Noy, Paul Hamlin, Matthew Matasar, Anita Kumar, Lorenzo Falchi, Joachim Yahalom, Steven Horwitz, Andrew Zelenetz, Anas Younes, Gilles Salles, Heiko Schöder, Erel Joffe
Published 2023-08-01
Article -
12
Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes by Yannis K. Valtis, Sean Devlin, Roni Shouval, Kai Rejeski, Magdalena Corona, Alejandro Luna De Abia, Alfredo Rivas-Delgado, Efrat Luttwak, Giulio Cassanello, Ivan Landego, Heiko Schöder, Akshay Bedmutha, Alexander Boardman, Gunjan L. Shah, Michael Scordo, Miguel-Angel Perales, Gilles Salles, M. Lia Palomba, Urvi A. Shah, Jae H. Park
Published 2025-01-01
Article -
13
<i>Erratum</i> to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation by Zachary D. Epstein-Peterson, Esther Drill, Umut Aypar, Connie Lee Batlevi, Philip Caron, Ahmet Dogan, Pamela Drullinsky, John Gerecitano, Paul A. Hamlin, Caleb Ho, Allison Jacob, Ashlee Joseph, Leana Laraque, Matthew J. Matasar, Alison J. Moskowitz, Craig H. Moskowitz, Chelsea Mullins, Colette Owens, Gilles Salles, Heiko Schöder, David J. Straus, Anas Younes, Andrew D. Zelenetz, Anita Kumar
Published 2024-08-01
Article -
14
Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation by Zachary D. Epstein-Peterson, Esther Drill, Umut Aypar, Connie Lee Batlevi, Philip Caron, Ahmet Dogan, Pamela Drullinsky, John Gerecitano, Paul A. Hamlin, Caleb Ho, Allison Jacob, Ashlee Joseph, Leana Laraque, Matthew J. Matasar, Alison J. Moskowitz, Craig H. Moskowitz, Chelsea Mullins, Colette Owens, Gilles Salles, Heiko Schöder, David J. Straus, Anas Younes, Andrew D. Zelenetz, Anita Kumar
Published 2023-08-01
Article -
15
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma by Reid W. Merryman, Laure Michaud, Robert Redd, Patrizia Mondello, Hyesun Park, Gabriela Spilberg, Matthew Robertson, Eleanor Taranto, Gulrayz Ahmed, Matthew Chase, Erin Jeter, Inhye E. Ahn, Jennifer R. Brown, Jennifer Crombie, Matthew S. Davids, David C. Fisher, Eric Jacobsen, Caron A. Jacobson, Austin I. Kim, Ann S. LaCasce, Samuel Y. Ng, Oreofe O. Odejide, Erin M. Parry, Gilles Salles, Andrew D. Zelenetz, Philippe Armand, Heiko Schöder, Heather Jacene
Published 2023-02-01
Article -
16
Conventional and novel [18F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma by Doris Leithner, Jessica R. Flynn, Sean M. Devlin, Audrey Mauguen, Teng Fei, Shang Zeng, Junting Zheng, Brandon S. Imber, Harper Hubbeling, Marius E. Mayerhoefer, Akshay Bedmutha, Efrat Luttwak, Magdalena Corona, Parastoo B. Dahi, Alejandro Luna de Abia, Ivan Landego, Richard J. Lin, M. Lia Palomba, Michael Scordo, Jae H. Park, Ana Alarcon Tomas, Gilles Salles, Daniel Lafontaine, Laure Michaud, Gunjan L. Shah, Miguel-Angel Perales, Roni Shouval, Heiko Schöder
Published 2024-04-01
Article -
17
Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes by Jennifer K. Lue, Efrat Luttwak, Alfredo Rivas-Delgado, Helen Irawan, Alexander Boardman, Philip C. Caron, Kevin David, Zachary Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Paul Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Alison Moskowitz, Ariela Noy, M. Lia Palomba, Ralphael Steiner, Robert Stuver, Pallawi Torka, Santosha Vardhana, Andrew D. Zelenetz, Heiko Schoder, Brandon Imber, Joachim Yahalom, Yanming Zhang, Pallavi Galera, Ahmet Dogan, Umut Aypar, Gilles Salles
Published 2024-10-01
Article -
18
T099: High efficacy and durability of second-line therapy with pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin in the phase II study for relapsed and refractory... by Alison J. Moskowitz, Gunjan Shah, Heiko Schöder, Nivetha Ganesan, Helen Hancock, Theresa Davey, Leslie Perez, Samia Sohail, Alayna Santarosa, Charisse Capadona, Brittney Munayirji, Anita Kumar, Oscar Lahoud, Connie Batlevi, Paul Hamlin, David J. Straus, Colette Owens, Philip Caron, Andrew Intlekofer, Audrey Hamilton, Steven Horwitz, Lorenzo Falchi, William Johnson, Lia Palomba, Ariela Noy, Matthew Matasar, Georgios Pongas, Gilles Salles, Santosha Vardhana, Beatriz Wills Sanin, Joachim Yahalom, Ahmet Dogan, Andrew Zelenetz, Craig H. Moskowitz
Published 2022-10-01
Article